BostonGene rakes in $50 mln Series A
BostonGene, a biomedical software provider, has raised $50 million in Series A funding. The investor was NEC Corporation.
26 April 2019•1 min read
BostonGene, a biomedical software provider, has raised $50 million in Series A funding. The investor was NEC Corporation.
